@article{MTMT:33761663,
	title = {Editorial: Developments in cardiac implantable electronic device therapy: how can we improve clinical implementation?},
	url = {https://m2.mtmt.hu/api/publication/33761663},
	author = {Vámos, Máté and Erath, Julia W. and Benz, Alexander P. and Duray, Gábor Zoltán},
	doi = {10.3389/fcvm.2023.1177882},
	journal-iso = {FRONT CARDIOVASC MED},
	journal = {FRONTIERS IN CARDIOVASCULAR MEDICINE},
	volume = {10},
	unique-id = {33761663},
	issn = {2297-055X},
	year = {2023},
	eissn = {2297-055X},
	orcid-numbers = {Duray, Gábor Zoltán/0000-0003-1286-6576}
}

@article{MTMT:31961506,
	title = {Reimplantation and long-term mortality after transvenous lead extraction in a high-risk, single-center cohort},
	url = {https://m2.mtmt.hu/api/publication/31961506},
	author = {Zsigmond, Előd-János and Miklós, Márton and Vida, Adorjan and Benák, Attila and Makai, Attila and Schvartz, Noémi and Klausz, Gergely and Hegedűs, Zoltán and Bogáts, Gábor and Sághy, László and Vámos, Máté},
	doi = {10.1007/s10840-021-00974-4},
	journal-iso = {J INTERV CARD ELECTR},
	journal = {JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY},
	volume = {66},
	unique-id = {31961506},
	issn = {1383-875X},
	year = {2023},
	eissn = {1572-8595},
	pages = {847-855},
	orcid-numbers = {Zsigmond, Előd-János/0000-0002-6487-3690; Vámos, Máté/0000-0003-1611-4443}
}

@article{MTMT:32551589,
	title = {2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)},
	url = {https://m2.mtmt.hu/api/publication/32551589},
	author = {Glikson, Michael and Nielsen, Jens Cosedis and Kronborg, Mads Brix and Michowitz, Yoav and Auricchio, Angelo and Barbash, Israel Moshe and Barrabes, Jose A. and Boriani, Giuseppe and Braunschweig, Frieder and Brignole, Michele and Burri, Haran and Coats, Andrew J. S. and Deharo, Jean-Claude and Delgado, Victoria and Diller, Gerhard-Paul and Israel, Carsten W. and Keren, Andre and Knops, Reinoud E. and Kotecha, Dipak and Leclercq, Christophe and Merkely, Béla Péter and Starck, Christoph and Thylen, Ingela and Maria, Tolosana Jose},
	doi = {10.1093/eurheartj/ehab364},
	journal-iso = {EUR HEART J},
	journal = {EUROPEAN HEART JOURNAL},
	volume = {42},
	unique-id = {32551589},
	issn = {0195-668X},
	keywords = {COMPLICATIONS; heart failure; bradycardia; TERM-FOLLOW-UP; GUIDELINES; syncope; QUALITY-OF-LIFE; Pacemaker; Bundle-Branch Block; Atrial Fibrillation; Cardiac pacing; cardiac resynchronization therapy; AORTIC-VALVE IMPLANTATION; SICK SINUS SYNDROME; EXPERT CONSENSUS STATEMENT; PERMANENT PACEMAKER IMPLANTATION; COMPLETE ATRIOVENTRICULAR-BLOCK; LEFT-VENTRICULAR LEAD; conduction system pacing; pacing indications; alternate site pacing; pacing in TAVI},
	year = {2021},
	eissn = {1522-9645},
	pages = {3427-3520},
	orcid-numbers = {Nielsen, Jens Cosedis/0000-0001-9414-1653; Merkely, Béla Péter/0000-0001-6514-0723; Nagy, Klaudia Vivien/0000-0001-6878-1892; Gellér, László Alajos/0000-0001-6802-6360}
}

@article{MTMT:34831805,
	title = {2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure},
	url = {https://m2.mtmt.hu/api/publication/34831805},
	author = {McDonagh, Theresa A and Metra, Marco and Adamo, Marianna and Gardner, Roy S and Baumbach, Andreas and Böhm, Michael and Burri, Haran and Butler, Javed and Čelutkienė, Jelena and Chioncel, Ovidiu and Cleland, John G F and Coats, Andrew J S and Crespo-Leiro, Maria G and Farmakis, Dimitrios and Gilard, Martine and Heymans, Stephane and Hoes, Arno W and Jaarsma, Tiny and Jankowska, Ewa A and Lainscak, Mitja and Lam, Carolyn S P and Lyon, Alexander R and McMurray, John J V and Mebazaa, Alexandre and Mindham, Richard and Muneretto, Claudio and Francesco Piepoli, Massimo and Price, Susanna and Rosano, Giuseppe M C and Ruschitzka, Frank and Kathrine Skibelund, Anne},
	doi = {10.1093/eurheartj/ehab368},
	journal-iso = {EUR HEART J},
	journal = {EUROPEAN HEART JOURNAL},
	volume = {42},
	unique-id = {34831805},
	issn = {0195-668X},
	keywords = {NATRIURETIC PEPTIDES; TRANSPLANTATION; diagnosis; hospitalization; heart failure; GUIDELINES; pharmacotherapy; ARRHYTHMIAS; cardiac resynchronization therapy; EJECTION FRACTION; acute heart failure; comorbidities; mechanical circulatory support; Multidisciplinary management; Advanced heart failure; neuro-hormonal antagonists},
	year = {2021},
	eissn = {1522-9645},
	pages = {3599-3726},
	orcid-numbers = {Sepp, Róbert/0000-0003-4964-1661}
}

@article{MTMT:31374312,
	title = {European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)},
	url = {https://m2.mtmt.hu/api/publication/31374312},
	author = {Blomström-Lundqvist, Carina and Traykov, Vassil and Erba, Paola Anna and Burri, Haran and Nielsen, Jens Cosedis and Bongiorni, Maria Grazia and Poole, Jeanne and Boriani, Giuseppe and Costa, Roberto and Deharo, Jean-Claude and Epstein, Laurence M and Sághy, László and Snygg-Martin, Ulrika and Starck, Christoph and Tascini, Carlo and Strathmore, Neil},
	doi = {10.1093/europace/euz246},
	journal-iso = {EUROPACE},
	journal = {EUROPACE},
	volume = {22},
	unique-id = {31374312},
	issn = {1099-5129},
	abstract = {Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially life-saving treatments for a number of cardiac conditions, but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased healthcare costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well recognized. Uncertainties have remained about the role of various preventive, diagnostic, and treatment measures such as skin antiseptics, pocket antibiotic solutions, anti-bacterial envelopes, prolonged antibiotics post-implantation, and others. Guidance on whether to use novel device alternatives expected to be less prone to infections and novel oral anticoagulants is also limited, as are definitions on minimum quality requirements for centres and operators and volumes. Moreover, an international consensus document on management of CIED infections is lacking. The recognition of these issues, the dissemination of results from important randomized trials focusing on prevention of CIED infections, and observed divergences in managing device-related infections as found in an European Heart Rhythm Association worldwide survey, provided a strong incentive for a 2019 International State-of-the-art Consensus document on risk assessment, prevention, diagnosis, and treatment of CIED infections.},
	keywords = {EXTRACTION; INFECTION; microbiology; endocarditis; re-implantation; cardiac resynchronization therapy; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; Cardiac implantable electronic devices; Pacemakers; Leads; EHRA consensus document},
	year = {2020},
	eissn = {1532-2092},
	pages = {515-549},
	orcid-numbers = {Gellér, László Alajos/0000-0001-6802-6360}
}

@article{MTMT:31384985,
	title = {Avoiding ICD lead revision in a patient with chronically low R-wave amplitudes. [esetismertetés]},
	url = {https://m2.mtmt.hu/api/publication/31384985},
	author = {Ernst, Matthias and Sághy, László and Hohnloser, Stefan H. and Vámos, Máté},
	doi = {10.26430/CHUNGARICA.2020.50.3.199},
	journal-iso = {CARDIOL HUNG},
	journal = {CARDIOLOGIA HUNGARICA},
	volume = {50},
	unique-id = {31384985},
	issn = {0133-5596},
	year = {2020},
	eissn = {1588-0230},
	pages = {199-201}
}

@article{MTMT:31402092,
	title = {2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS},
	url = {https://m2.mtmt.hu/api/publication/31402092},
	author = {Bongiorni, Maria G and Burri, Haran and Deharo, Jean C and Starck, Christoph and Kennergren, Charles and Sághy, László and Rao, Archana and Tascini, Carlo and Lever, Nigel and Kutarski, Andrzej and Fernandez Lozano, Ignacio and Strathmore, Neil and Costa, Roberto and Epstein, Laurence and Love, Charles and Blomstrom-Lundqvist, Carina},
	doi = {10.1093/europace/euy050},
	journal-iso = {EUROPACE},
	journal = {EUROPACE},
	volume = {20},
	unique-id = {31402092},
	issn = {1099-5129},
	year = {2018},
	eissn = {1532-2092}
}

@article{MTMT:30390437,
	title = {Efficacy and safety of transvenous lead extraction in 108 consecutive patients: a single-centre experience.},
	url = {https://m2.mtmt.hu/api/publication/30390437},
	author = {Monsefi, Nadejda and Waraich, Harmeet Singh and Vámos, Máté and Erath, Julia and Sirat, Sami and Moritz, Anton and Hohnloser, Stefan H},
	doi = {10.1093/icvts/ivy351},
	journal-iso = {INTERACT CARDIOVAS THOR SURG},
	journal = {INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY},
	volume = {28},
	unique-id = {30390437},
	issn = {1569-9293},
	abstract = {The number of cardiac implantable electronic devices is growing worldwide because they play a relevant role in improving the survival rate in patients with specific heart diseases. Cardiac implantable electronic devices complications including infection, dysfunction or venous stenosis increase the need for the least traumatic way to explant leads. Our goal was to report the successes and procedural complication rates of transvenous lead extraction (TLE) in a consecutive series of patients.From 2010 to 2016, 108 patients underwent TLE of 227 leads due to endocarditis (n = 21; 19%), pocket infection (n = 58; 54%) or lead dysfunction (n = 29; 27%). In 98% (n = 106) of the patients, laser-assisted lead extraction was performed. In 2% (n = 2) of the patients, the application of a solitary locking stylet was sufficient. The patient mean age was 68 ± 14 years; 25% of the patients had previous cardiac surgery. TLE was performed a mean of 9 ± 6 years after the implantation of the existing device.Complete procedural success (removal of all lead material from the vascular space) was achieved in 98.7% (n = 224), and clinical success (achievement of all clinical goals associated with the indication for lead removal and absence of major complications) was achieved in 98% (n = 106). In 2 patients the procedure failed due to a vascular tear requiring a thoracotomy. In 1 patient, complete lead extraction was not possible due to heavy calcification (coronary-sinus lead). The 30-day mortality rate was 3.7% (n = 4); the patients died of multiorgan failure (n = 1), cardiac failure (n = 1) and septicaemia (n = 2). The procedure-related major complication rate was 2% (n = 2).Laser-assisted TLE seems to be a safe and effective procedure with an acceptable complication rate.},
	year = {2018},
	eissn = {1569-9285},
	pages = {704-708}
}